Stansberry Asset Management’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-286,100
Closed -$28.4M 56
2019
Q3
$28.4M Sell
286,100
-102,316
-26% -$9.72M 12.56% 1
2019
Q2
$35.9M Buy
388,416
+148,726
+62% +$14.1M 14.13% 1
2019
Q1
$22.6M Buy
+239,690
New +$21M 7.76% 2

Other funds holding CELG

Stansberry Asset Management's CELG Position: Q4 2019 in Review

Stansberry Asset Management sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 286,100 shares — an estimated $28.4M sold.

Stansberry Asset Management first reported a position in CELG in Q1 2019 and held it in 3 quarters. The position peaked at $35.9M in Q2 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Stansberry Asset Management reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Stansberry Asset Management sold 286,100 Celgene Corp shares in Q4 2019, an estimated $28.4M.
  • Stansberry Asset Management first reported a position in Celgene Corp in Q1 2019 and held it in 3 quarters.
  • Stansberry Asset Management's Celgene Corp position peaked at $35.9M in Q2 2019.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Stansberry Asset Management's 13F filing for Q4 2019, filed 14 Feb 2020.